We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

When it was approved in March 2024, Rezdiffra became the only medicine approved by the Food and Drug Administration (FDA) to ...

Kennedy Jr.'s potential appointment to the Department of Health and Human Services has spooked Eli Lilly stock and shares of other companies that make popular weight-loss drugs.Please watch the video ...

Barclays analysts are bullish on Novo Nordisk (NYSE:NVO) stock ahead of the December release of pivotal clinical trial data ...

Donald Trump’s victory in the US presidential election has sent the overall stock market higher. But it’s been a different story for healthcare stocks.

As far as competition goes, Eli Lilly is one of the two current leaders in the weight loss space, along with Novo Nordisk.

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...

Eli Lilly, Novo Nordisk, and Amgen all look cheap. All of them could experience a massive boost to profits in the years to ...

Despite attractive valuation metrics, Hershey faces challenges like stagnant earnings growth. Read why HSY stock is a ...

Gilliland Jeter Wealth Management LLC raised its holdings in Novo Nordisk A/S by 200.0% in the 2nd quarter. Gilliland Jeter Wealth Management LLC now owns 180 shares of the company’s stock valued at ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

Novo Nordisk A/S's short interest — meaning the percentage of the share float that is being shorted — is lower than average ...